StockWatch
·

SMS PHARMACEUTICALS LTD. Q4 FY25 Results

SMSPHARMAQ4 FY25 Results
Filing
MetricValue ( Cr)vs Q3 FY25
Revenue248.2043.2%
Total Income249.6242.3%
Expenditure221.0944.5%
PBT28.5227.1%
Net Profit20.3111.4%
OPM16.44%12.16pp
NPM8.14%1.59pp
EPS2.4011.6%
View full financials

Informational and educational content only. Not investment advice.